TY  - GEN
AU  - Eisen,Alon
AU  - Giugliano,Robert P
AU  - Ruff,Christian T
AU  - Nordio,Francesco
AU  - Gogia,Harinder S
AU  - Awasty,Vivek R
AU  - Henderson,David A
AU  - Mercuri,Michele F
AU  - Rutman,Howard
AU  - Antman,Elliott M
AU  - Braunwald,Eugene
TI  - Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48 (ENGAGE AF-TIMI 48) trial
SN  - 1097-6744
PY  - 2016///0614
KW  - Aged
KW  - Anticoagulants
KW  - administration & dosage
KW  - Atrial Fibrillation
KW  - complications
KW  - Blood Coagulation
KW  - drug effects
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Drug Approval
KW  - Factor Xa
KW  - Factor Xa Inhibitors
KW  - Female
KW  - Humans
KW  - Male
KW  - Myocardial Infarction
KW  - Pyridines
KW  - Stroke
KW  - blood
KW  - Thiazoles
KW  - Thrombolytic Therapy
KW  - methods
KW  - United States
KW  - United States Food and Drug Administration
KW  - Warfarin
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1016/j.ahj.2015.11.004
ER  -